A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia) (VENCLL regPMOS)

AbbVie

Status: Completed

Conditions: Small Lymphocytic Leukemia (SLL); Cancer; Chronic Lymphocytic Leukemia (CLL)

Study type: Observational

Funder types: Industry

Identifiers

NCT04198415

P19-830

Details and patient eligibility

About

This study will collect real-world safety and efficacy data from Japanese relapse/refractory chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL) participants treated with venetoclax.

Enrollment: 4 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

-Prescribed and treated with venetoclax

Exclusion criteria

None

Trial design

4 participants in 1 patient group

Venetoclax Participants

Description:

Participants prescribed and treated with venetoclax.